CompletedPhase 2NCT02451696

A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD

Studying Epilepsy syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
NYU Langone Health
Principal Investigator
Orrin Devinsky, MD
NYU Langone Health
Intervention
Everolimus(drug)
Enrollment
15 enrolled
Eligibility
2-40 years · All sexes
Timeline
20142017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02451696 on ClinicalTrials.gov

Other trials for Epilepsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Epilepsy syndrome

← Back to all trials